News Center

Home page

Peak Report

News reports

A busy and challenging year.

Release time:

2021-03-01

Group Company 2020 Outstanding Employee Pharmaceutical Company Peak Pharmaceutical Factory Wang Junyang

Looking back on this year's work, it was busy and full of challenges. The preparation workshop concentrates on the production of multiple products, especially when the eye drops / ear liquid line and the API production line are produced at the same time, the time is tight and the production task is heavy. As a craftsman, on-site inspection and supervision are under great pressure. I reasonably allocated time and completed various process control to ensure the smooth progress of production tasks.

This year, in addition to completing the production tasks, the workshop also carried out a number of technological innovation and transformation projects. In the artificial bezoar technological transformation project, I participated in the transformation of the condensate collection device of the vacuum pipeline of the drying equipment, the on-site inspection of the manufacturer of the ultrasonic oscillating screen and the equipment selection, and improved the efficiency of drying and sieving. The sieving time was reduced from 14 hours per batch to 3 hours, and ensured that the sieving and the next batch of feeding could be completed in one shift, thus improving the production efficiency and reducing the production cost, shorten the production cycle. In the technical renovation project of the water for injection system pipeline and the liquid distribution system of the eye drop line, I worked overtime to debug and optimize the program for many times according to the production process of the product, and repeatedly tested and confirmed each key parameter. In the process, many deficiencies were found in the program, such as the problem that the bottom valve of the liquid storage tank was not opened and the liquid medicine could not be delivered to the production line under the automatic medicine delivery program of the liquid distribution system, timely report to the leaders and conduct feedback communication with factory engineers on site, and remove the problems and defects one by one until the production requirements are met. In the new project of ethylene oxide sterilization process, I was responsible for the debugging and optimization of the equipment and the technical exchange with the engineers of the manufacturer. In the follow-up verification work, I was responsible for the drafting of the verification scheme, the development of the verification work and the deployment of personnel, and successfully completed the relevant verification work to ensure that the production tasks were carried out on time. In the consistency evaluation of sodium hyaluronate eye drops and the trial production of tamoxifin eye drops and moxifloxacin hydrochloride eye drops, I participated in the whole process from the first draft of the research plan to the formation of standard documents conforming to pharmaceutical companies. I also participated in the whole process to guide the operation feasibility of the process flow, the conformity of equipment and technology, the rationality of sampling, and actively participated in the analysis and discussion of abnormal conditions, my opinions and ideas were given and adopted, the problems were solved in time, and the verification batch production of consistency evaluation and the trial production of new products were successfully completed.

I believe that the new year will also be full of opportunities and challenges. In the following work, I will also uphold the enterprise spirit of "unity and struggle, realistic and innovative, determined to be the top, and bravely climb the peak " , constantly improve my quality awareness, strengthen professional knowledge reserve, improve working ability, stick to my job and strive for innovation, to ensure the quality of drugs as the fundamental, to improve production efficiency for the purpose, improve the production process, save production costs. Keep in mind the purpose of the enterprise, contribute to the creation of "Centennial Peak " with more standardized management, more effective execution and more rigorous attitude with full work enthusiasm and indomitable fighting spirit.

(according to Wang Junyang's speech at the summary and commendation meeting of the pharmaceutical company)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页